Goodman DW. Mental Illness in Primary Care. Oxford Press. 2015. (book chapter)
Tag: David W. Goodman MD
13
Oct2015
On September 30, 2015, The New York Times ran an article in the Tuesday Science section on ADHD in older adults. I was interviewed for the article and discussed a former patient age 73 who was first diagnosis with ADHD by me and successfully treated. The article is an introduction ... Read More
October 13, 2015David W. Goodman, MD
20
Apr2015
In my periodic entries of insurance companies' denial of ADHD medication dosing, I offer you this recent example.
A female in her late 20s treated for ADHD with a combination of Adderall XR and Strattera. Strattera adds a benefit for her executive function not optimized with Adderall XR. I carefully dosed ... Read More
April 20, 2015David W. Goodman, MD
02
Mar2015
Chris Davis set a club record last year with 53 home runs. Yet, his presence in the media now has more to do with his ADHD and suspension for the use of Adderall. This has been a set of unfortunate circumstances since Mr. Davis has ADHD which was diagnosed years ... Read More
March 2, 2015David W. Goodman, MD
04
Feb2015
You might think you're exercising good judgment by enhancing your health and wellbeing by taking herbs and supplements. While the scientific research with replicated studies is limited, the nutraceutical companies have spent billions promoting their use. Yet now, the real problem is uncovered. The New York Times recently published a ... Read More
February 4, 2015David W. Goodman, MD
22
Jan2015
For those of you who follow my blog and others who have stumbled upon it, I wanted to bring this opportunity to your attention. Shire Pharmaceutical annually provides these scholarships to help students with ADHD get ahead. If you are interested and eligible, please look into this.
The 2015 Scholarship program ... Read More
January 22, 2015David W. Goodman, MD
04
Jan2015
Almost everyday insurance companies request pre-authorization for stimulant medication for my patients. While many of these requests are approved, many others are not. One obstacle to approval is stimulant dosing. Insurance companies routinely deny coverage for any stimulant dose that exceeds FDA drug label maximum dose. You might believe this ... Read More
January 4, 2015David W. Goodman, MD
08
Dec2014
Over the years, it has been challenging for psychiatrists to manage the risks of psychiatric medications in patients who considered childbearing, become pregnant, and chose to breastfeed. And while there is some information on many psychiatric medications, there remains little in regards to stimulant medications. Unfortunately, there is no registry ... Read More
December 8, 2014David W. Goodman, MD
16
Jul2014
If you're reading this blog, you are one of the millions of people who now use the Internet to gain information on medical issues. In a recent survey of consumers, this is where people are looking for medical information.
Most accessed online resources:
53% web M.D.
22% Wikipedia
19% health magazines and websites
16% advocacy ... Read More
July 16, 2014David W. Goodman, MD
07
Mar2014
Since many of my patients are on this antidepressant, I am posting the FDA warning issued this morning. Below is a copy of the text. Please see the link at the bottom of this blog for additional information.
Effexor XR 150 Mg Extended-Release Capsules (Pfizer) and Venlafaxine HCl 150 Mg Extended-Release ... Read More
March 7, 2014David W. Goodman, MD